| Agora, Inc. Reports First Quarter 2024 Financial Results |
Globe Newswire |
05/23 |
02:00 |
| Profire Energy Announces $2 Million Share Buyback Program |
Globe Newswire |
05/23 |
01:10 |
| ROHM Semiconductor and Nanjing SemiDrive Technology Jointly Develop a Reference Design: Utilizing PMICs and SerDes ICs for SoC |
Globe Newswire |
05/23 |
01:00 |
| Progyny, Inc. Announces Additional Share Repurchase Program |
Globe Newswire |
05/23 |
01:00 |
| Adagene to Present at Investor Conferences in June |
Globe Newswire |
05/23 |
00:45 |
| Codexis to Participate in Jefferies Global Healthcare Conference |
Globe Newswire |
05/23 |
00:25 |
| NVIDIA Announces Financial Results for First Quarter Fiscal 2025 |
Globe Newswire |
05/23 |
00:20 |
| Uniti Group Inc. to Present at the TD Cowen 52nd Annual Technology, Media and Telecom Conference |
Globe Newswire |
05/23 |
00:15 |
| Crown Castle Declares Quarterly Common Stock Dividend |
Globe Newswire |
05/23 |
00:15 |
| California Water Service Group Bolsters Environmental, Social, and Governance Program, Reaffirms Commitment to Safe and Reliable Water Supply for Communities |
Globe Newswire |
05/23 |
00:15 |
| Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference |
Globe Newswire |
05/23 |
00:15 |
| Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program |
Globe Newswire |
05/23 |
00:10 |
| Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline |
Globe Newswire |
05/23 |
00:10 |
| GlobalFoundries Announces Launch of $950 Million Secondary Offering of Ordinary Shares, Including Concurrent $200 Million Share Repurchase |
Globe Newswire |
05/23 |
00:06 |
| ThredUp to Participate in William Blair Conference |
Globe Newswire |
05/23 |
00:05 |
| Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma |
Globe Newswire |
05/23 |
00:05 |
| 89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress |
Globe Newswire |
05/23 |
00:05 |
| LiveRamp Announces Fourth Quarter and Fiscal Year Results |
Globe Newswire |
05/23 |
00:05 |
| Nyxoah Announces Proposed Offering of Ordinary Shares |
Globe Newswire |
05/23 |
00:05 |
| NANO Nuclear Energy Announces Closing of Full Over-Allotment Option from Initial Public Offering |
Globe Newswire |
05/23 |
00:01 |
| European Wax Center, Inc. Announces Participation in the Baird 2024 Global Consumer, Technology & Services Conference |
Globe Newswire |
05/23 |
00:01 |
| Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline |
Globe Newswire |
05/23 |
00:00 |
| DP World Receives First Freighter Aircraft at New Air Cargo Logistics Hub in Dominican Republic |
Globe Newswire |
05/22 |
23:56 |
| Alabama Futures Fund Invests in IQID Technology, Inc. |
Globe Newswire |
05/22 |
23:37 |
| WattEV to expand fleet of heavy-duty electric trucks to more than 180 |
Globe Newswire |
05/22 |
23:30 |
